Floor and ceiling effects on the Montreal Cognitive Assessment in patients with Parkinson’s disease in Brazil

ABSTRACT Parkinson’s disease (PD) is a common neurodegenerative disease associated with cognitive impairment. The Montreal Cognitive Assessment (MoCA) has been used as a recommended global cognition scale for patients with PD, but there are some concerns about its application, partially due to the floor and ceiling effects. Objective: To explore the floor and ceiling effects on the MoCA in patients with PD in Brazil. Methods: Cross-sectional study with data from patients with PD from five Brazilian Movement Disorders Clinics, excluding individuals with a possible diagnosis of dementia. We analyzed the total score of the MoCA, as well as its seven cognitive domains. The floor and ceiling effects were evaluated for the total MoCA score and domains. Multivariate analyses were performed to detect factors associated with floor and ceiling effects. Results: We evaluated data from 366 patients with PD and approximately 19% of individuals had less than five years of education. For the total MoCA score, there was no floor or ceiling effect. There was a floor effect in the abstraction and delayed memory recall domains in 20% of our sample. The ceiling effect was demonstrated in all domains (80.8% more common in naming and 89% orientation), except delayed recall. Education was the main factor associated with the floor and ceiling effects, independent of region, sex, age at evaluation, and disease duration. Conclusion: The floor and ceiling effects are present in specific domains of the MoCA in Brazil, with a strong impact on education. Further adaptations of the MoCA structure for underrepresented populations may reduce these negative effects.

[1]  Sonia Maria Dozzi Brucki,et al.  Subjective cognitive decline, mild cognitive impairment, and dementia - syndromic approach: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology , 2022, Dementia & neuropsychologia.

[2]  C. Dowrick,et al.  Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority. , 2022, JAMA neurology.

[3]  Qimin Liu,et al.  t-Test and ANOVA for data with ceiling and/or floor effects , 2020, Behavior Research Methods.

[4]  M. Yassuda,et al.  MoCA Test: normative and diagnostic accuracy data for seniors with heterogeneous educational levels in Brazil. , 2019, Arquivos de neuro-psiquiatria.

[5]  K. J. Almeida,et al.  Cut-off points of the Portuguese version of the Montreal Cognitive Assessment for cognitive evaluation in Parkinson’s disease , 2019, Dementia & neuropsychologia.

[6]  B. Bloem,et al.  The Emerging Evidence of the Parkinson Pandemic , 2018, Journal of Parkinson's disease.

[7]  C. Suemoto,et al.  Normative data for the Montreal Cognitive Assessment (MoCA) and the Memory Index Score (MoCA‐MIS) in Brazil: Adjusting the nonlinear effects of education with fractional polynomials , 2018, International journal of geriatric psychiatry.

[8]  Stefano Tamburin,et al.  MoCA for cognitive screening in Parkinson's disease: Beware of floor effect , 2018, Movement disorders : official journal of the Movement Disorder Society.

[9]  M. Jahanshahi,et al.  Global scales for cognitive screening in Parkinson's disease: Critique and recommendations , 2018, Movement disorders : official journal of the Movement Disorder Society.

[10]  I. Mata,et al.  Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease , 2016, Dementia & neuropsychologia.

[11]  Ji In Kim,et al.  The MMSE and MoCA for Screening Cognitive Impairment in Less Educated Patients with Parkinson’s Disease , 2016, Journal of movement disorders.

[12]  S. Hemrungrojn,et al.  The Montreal Cognitive Assessment—Basic: A Screening Tool for Mild Cognitive Impairment in Illiterate and Low‐Educated Elderly Adults , 2015, Journal of the American Geriatrics Society.

[13]  I. Mata,et al.  Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised. , 2015, Arquivos de neuro-psiquiatria.

[14]  M. Zunzunegui,et al.  Applicability of the MoCA‐S test in populations with little education in Colombia , 2013, International journal of geriatric psychiatry.

[15]  M. Yassuda,et al.  Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment , 2013, International journal of geriatric psychiatry.

[16]  A. Lees,et al.  The relevance of the Lewy Body to the pathogenesis of idiopathic Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  R. Barker,et al.  Mild cognitive impairment in Parkinson disease , 2010, Neurology.

[18]  J. Gallo,et al.  The Mini-mental State Examination revisited: ceiling and floor effects after score adjustment for educational level in an aging Mexican population , 2009, International Psychogeriatrics.

[19]  B. Ravina,et al.  The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[20]  B. Uttl,et al.  Measurement of Individual Differences , 2005, Psychological science.

[21]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[22]  C. McHorney,et al.  Individual-patient monitoring in clinical practice: are available health status surveys adequate? , 1995, Quality of Life Research.

[23]  M. Shaikh,et al.  Cross-Cultural Applicability of the Montreal Cognitive Assessment (MoCA): A Systematic Review. , 2017, Journal of Alzheimer's disease : JAD.